No Structure Information
This entry has no structure information.
To add it, be sure the Wikipedia entry contains a valid CAS number in its "Chembox", "Chembox new", "Drugbox", or "Explosivebox" template.
Even with a valid CAS number, structural information may not appear because of limitations in Chempedia's database. Stay tuned for developments in this area.
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug that selectively blocks the platelet glycoprotein IIb/IIIa receptor. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarus barbouri). It belongs to the class of the so called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
4 edits since May 19, 2008. Last edited Jul 26, 2008 by Fvasconcellos (176).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Eptifibatide. See this site's terms for details.